- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Next generation self-replicating RNA vectors for vaccines and immunotherapies ; day:22 ; month:2 ; year:2022 ; pages:1-9
Cancer gene therapy ; (22.2.2022), 1-9
- Creator
-
Aliahmad, Parinaz
Miyake-Stoner, Shigeki J.
Geall, Andrew J.
Wang, Nathaniel S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41417-022-00435-8
- URN
-
urn:nbn:de:101:1-2022102700143715149531
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aliahmad, Parinaz
- Miyake-Stoner, Shigeki J.
- Geall, Andrew J.
- Wang, Nathaniel S.
- SpringerLink (Online service)
Other Objects (12)
Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
Rapid Transient Production in Plants by Replicating and Non-Replicating Vectors Yields High Quality Functional Anti-HIV Antibody
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
Target discovery for T cell therapy: next steps to advance Immunotherapies
Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines
DNA Replicons : next generation vaccines against allergy
P12-07. Novel HIV vaccines using chimeric influenza HA vectors
Cancer vaccines at an inflexion point: what next?
Immunotherapies in solid tumors
Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
Rapid Transient Production in Plants by Replicating and Non-Replicating Vectors Yields High Quality Functional Anti-HIV Antibody
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
Target discovery for T cell therapy: next steps to advance Immunotherapies
Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines
DNA Replicons : next generation vaccines against allergy
P12-07. Novel HIV vaccines using chimeric influenza HA vectors
Cancer vaccines at an inflexion point: what next?
Immunotherapies in solid tumors
Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
Rapid Transient Production in Plants by Replicating and Non-Replicating Vectors Yields High Quality Functional Anti-HIV Antibody
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
Target discovery for T cell therapy: next steps to advance Immunotherapies
Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines
DNA Replicons : next generation vaccines against allergy
P12-07. Novel HIV vaccines using chimeric influenza HA vectors
Cancer vaccines at an inflexion point: what next?